» Articles » PMID: 26690562

Waterborne Elizabethkingia Meningoseptica in Adult Critical Care

Overview
Date 2015 Dec 23
PMID 26690562
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Elizabethkingia meningoseptica is an infrequent colonizer of the respiratory tract; its pathogenicity is uncertain. In the context of a 22-month outbreak of E. meningoseptica acquisition affecting 30 patients in a London, UK, critical care unit (3% attack rate) we derived a measure of attributable morbidity and determined whether E. meningoseptica is an emerging nosocomial pathogen. We found monomicrobial E. meningoseptica acquisition (n = 13) to have an attributable morbidity rate of 54% (systemic inflammatory response syndrome ≥2, rising C-reactive protein, new radiographic changes), suggesting that E. meningoseptica is a pathogen. Epidemiologic and molecular evidence showed acquisition was water-source-associated in critical care but identified numerous other E. meningoseptica strains, indicating more widespread distribution than previously considered. Analysis of changes in gram-negative speciation rates across a wider London hospital network suggests this outbreak, and possibly other recently reported outbreaks, might reflect improved diagnostics and that E. meningoseptica thus is a pseudo-emerging pathogen.

Citing Articles

Large-scale genomic analysis of Elizabethkingia anophelis.

Andriyanov P, Zhurilov P, Menshikova A, Tutrina A, Yashin I, Kashina D BMC Genomics. 2024; 25(1):1015.

PMID: 39472795 PMC: 11523902. DOI: 10.1186/s12864-024-10921-y.


Mortality Risk and Antibiotic Therapy for Patients with Infections Caused by Species-A Meta-Analysis.

Huang C, Kuo S, Lin L Medicina (Kaunas). 2024; 60(9).

PMID: 39336571 PMC: 11433677. DOI: 10.3390/medicina60091529.


Identification of novel Tet(X6)-Tet(X2) recombinant variant in from a bullfrog farm and downstream river in China.

Jin H, Jia Q, Jin X, Zhu X, Wang M, Sun R Front Microbiol. 2024; 15:1453801.

PMID: 39144213 PMC: 11322121. DOI: 10.3389/fmicb.2024.1453801.


Synergistic Antimicrobial Effects of Ibuprofen Combined with Standard-of-Care Antibiotics against Cystic Fibrosis Pathogens.

Chen Q, Ilanga M, Simbassa S, Chirra B, Shah K, Cannon C Biomedicines. 2023; 11(11).

PMID: 38001937 PMC: 10669699. DOI: 10.3390/biomedicines11112936.


Review on infection control strategies to minimize outbreaks of the emerging pathogen Elizabethkingia anophelis.

Mallinckrodt L, Huis In t Veld R, Rosema S, Voss A, Bathoorn E Antimicrob Resist Infect Control. 2023; 12(1):97.

PMID: 37679842 PMC: 10486102. DOI: 10.1186/s13756-023-01304-1.


References
1.
Lee C, Chen P, Wang L, Lee H, Chang C, Lee N . Fatal case of community-acquired bacteremia and necrotizing fasciitis caused by Chryseobacterium meningosepticum: case report and review of the literature. J Clin Microbiol. 2006; 44(3):1181-3. PMC: 1393108. DOI: 10.1128/JCM.44.3.1181-1183.2006. View

2.
Henriques I, Araujo S, Azevedo J, Alves M, Chouchani C, Pereira A . Prevalence and diversity of carbapenem-resistant bacteria in untreated drinking water in Portugal. Microb Drug Resist. 2012; 18(5):531-7. DOI: 10.1089/mdr.2012.0029. View

3.
Maraki S, Scoulica E, Manoura A, Papageorgiou N, Giannakopoulou C, Galanakis E . A Chryseobacterium meningosepticum colonization outbreak in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis. 2009; 28(12):1415-9. DOI: 10.1007/s10096-009-0797-2. View

4.
Bellais S, Aubert D, Naas T, Nordmann P . Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum. Antimicrob Agents Chemother. 2000; 44(7):1878-86. PMC: 89979. DOI: 10.1128/AAC.44.7.1878-1886.2000. View

5.
Hsu M, Liao C, Huang Y, Liu C, Yang C, Kao K . Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006. Eur J Clin Microbiol Infect Dis. 2011; 30(10):1271-8. DOI: 10.1007/s10096-011-1223-0. View